Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

DARPP-32 expression in rat brain after electroconvulsive stimulation.

Daniela V F Rosa1, Renan P Souza, Bruno R Souza

  • 1Grupo de Pesquisa em Neuropsiquiatria Clínica e Molecular, Universidade Federal de Minas Gerais, Av Antonio Carlos 6627, Belo Horizonte 31270-901, Minas Gerais, Brazil.

Brain Research
|October 9, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Spinal cord hypometabolism associated with infection by human T-cell lymphotropic virus type 1(HTLV-1).

PLoS neglected tropical diseases·2018
Same author

Increased oxidative stress in the mitochondria isolated from lymphocytes of bipolar disorder patients during depressive episodes.

Psychiatry research·2018
Same author

Food addiction: Prevalence, psychopathological correlates and associations with quality of life in a large sample.

Journal of psychiatric research·2017
Same author

The inhibition of the kynurenine pathway prevents behavioral disturbances and oxidative stress in the brain of adult rats subjected to an animal model of schizophrenia.

Progress in neuro-psychopharmacology & biological psychiatry·2017
Same author

Lithium and Tamoxifen Modulate Behavior and Protein Kinase C Activity in the Animal Model of Mania Induced by Ouabain.

The international journal of neuropsychopharmacology·2017
Same author

Mechanism of synergistic action on behavior, oxidative stress and inflammation following co-treatment with ketamine and different antidepressant classes.

Pharmacological reports : PR·2017

Electroconvulsive stimulation (ECS) affects DARPP-32 protein expression. Chronic ECS, unlike acute ECS, transiently increases DARPP-32 in rat brain regions, offering insights into electroconvulsive therapy (ECT) mechanisms.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Pharmacology

Background:

  • Electroconvulsive therapy (ECT) remains a vital treatment for mental disorders, yet its underlying mechanisms are poorly understood.
  • Dopamine and cyclic AMP-regulated phosphoprotein, Mr 32,000 (DARPP-32) is crucial in dopaminergic signaling pathways.
  • Investigating DARPP-32 expression changes following electroconvulsive stimulation (ECS) can elucidate ECT's effects.

Purpose of the Study:

  • To analyze the expression of DARPP-32 in specific rat brain regions after acute and chronic ECS.
  • To determine the temporal dynamics of DARPP-32 expression changes post-ECS.
  • To correlate these changes with potential therapeutic and adverse effects of ECT.

Main Methods:

  • Wistar rats were subjected to either a single (acute) or a series of eight (chronic) ECS.

Related Experiment Videos

  • Tissue samples from striatum, cortex, hippocampus, and cerebellum were collected at various time points post-stimulation.
  • DARPP-32 protein expression levels were analyzed using established biochemical techniques.

    • Main Results:

    • Acute ECS induced minimal changes in DARPP-32 expression.
    • Chronic ECS led to a transient increase in DARPP-32 expression in the striatum and hippocampus at specific time points after the final stimulation.
    • These alterations suggest a differential impact of acute versus chronic ECS on dopaminergic signaling.

    Conclusions:

    • Chronic ECS significantly alters DARPP-32 expression in key brain areas involved in mood regulation.
    • Findings provide novel insights into the molecular mechanisms of ECS, potentially explaining its therapeutic and adverse effects.
    • Further research into DARPP-32 modulation could inform the development of more targeted neuropsychiatric treatments.